Artios
Artios is a UK-based biotech developing cancer treatments by targeting DNA damage repair pathways in tumors, with two lead drug candidates in clinical trials. The company has raised $413M, including a Series D in late 2025, and employs 128 people.
The growth story
Artios grew from 94 to 128 employees between 2022 and 2026, raising $413M along the way, most recently a Series D in November 2025.
About
Artios develops small molecule drugs that exploit cancer cells' reliance on DNA repair mechanisms, with programs targeting ATR and Polθ enzymes for solid tumors. Its DcoDeR platform systematically identifies new DDR targets for oncology applications.
The company has advanced two candidates to clinical trials as both monotherapies and combination treatments. Its $413M funding and collaborations with major institutions suggest strong investor confidence in its DDR-focused approach to oncology.
Founders and leadership
Research dominates Artios' organization, accounting for 23 staff. The company maintains academic ties, with leadership likely drawing from its founders' DNA repair expertise and pharmaceutical industry veterans.
The Artios org chart
Michael Andriole (President, CEO and Director) leads 42 mapped leaders with 5 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 45 (-6% YoY), Business Development 28 (+4% YoY), Healthcare Services 8 (+60% YoY), Education 6 (0% YoY), Legal 3 (+50% YoY), Community and Social Services 3 (+200% YoY).
Talent flow
Artios recruits heavily from AstraZeneca (13 hires) and Eli Lilly (8), with 5+ hires each from GSK and Cambridge University. Alumni frequently move to cancer research organizations, with Cancer Research Horizons and AstraZeneca being top destinations.
Most common previous employers of Artios staff: AstraZeneca (13), Eli Lilly and Company (8), Chimerix, a Jazz Pharmaceuticals Company (6), GSK (5), University of Cambridge (5), Mission Therapeutics (5). Former Artios employees most often moved to Cancer Research Horizons (3), AstraZeneca (3), GSK (2), Pierre Fabre Laboratories (2), ViaNautis (2), Brandon Capital (1).
Alumni worth knowing
The Artios mafia
Artios alumni founded three biotechs: Scancell (58 staff), Verinnogen (8 staff), and ALTX Therapeutics, all focused on novel therapeutic approaches.
3Phil L'Huillier, was Non Executive Director until 2017Isaac Johnson, was Scientist until 2021Simon Boulton, was Co-founder & VP Science Strategy until 2025Web traffic
Traffic mix: 42% direct, 40% search, 9% social, 1% paid.
What this company is made of
Most common skills at Artios: Pharmaceutics (29), Research Skills (28), Project Management (27), Life Sciences (25), Polymerase Chain Reaction (PCR) (24), Leadership (24), Drug Development (24), Molecular Biology (21).
Where the team actually sits
Artios people are concentrated in England, United Kingdom (33), Greater Cambridge Area (12), United Kingdom (9), North Carolina, United States (3).
Search footprint
Artios attracts about 198 organic search visits a month, traffic worth roughly $1K a month if bought through ads. It gained 20 ranking keywords and lost 40 in the last period.
Frequently asked
Artios has 128 employees as of September 2026.
Artios has raised $413M in total, most recently a Series D round in November 2025.
Michael Andriole (President, CEO and Director) sits at the top of Artios's reporting structure, with 5 direct reports.
The most common previous employers of current Artios staff are AstraZeneca (13 people), Eli Lilly and Company (8 people), Chimerix, a Jazz Pharmaceuticals Company (6 people).
Former Artios employees most often move to Cancer Research Horizons (3), AstraZeneca (3), GSK (2).
At least 3 companies have a founder who previously worked at Artios, including Scancell, Verinnogen, ALTX Therapeutics.
Artios attracts about 198 organic search visits a month, worth roughly $1K a month in equivalent ad spend.
The most common skills among Artios staff are Pharmaceutics, Research Skills, Project Management, Life Sciences, Polymerase Chain Reaction (PCR).
Artios staff are concentrated in England, United Kingdom (33), Greater Cambridge Area (12), United Kingdom (9).
Artios has about 45 people in Research, down 6% over the past year, as of September 2026.
Artios has about 28 people in Business Development, up 4% over the past year, as of September 2026.
Computed from 70 current and 103 former Artios profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.